Rheumatoid Arthritis Clinical Trials in Los Angeles, California

3 studies are recruiting for rheumatoid arthritis in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Nkarta Investigational Site, Los Angeles, California
    Locations
    12 in total
    Run by
    Nkarta, Inc.

    See if you can join NCT06733935 on ClinicalTrials.gov

  2. A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

    This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Cedars Sinai Medical Center, Los Angeles, California
    Locations
    65 in total
    Run by
    Hoffmann-La Roche

    See if you can join NCT07137598 on ClinicalTrials.gov

  3. RA-PRO PRAGMATIC TRIAL

    The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Pacific Arthritis Care Center, Los Angeles, California
    Locations
    49 in total
    Run by
    University of Alabama at Birmingham

    See if you can join NCT04692493 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.